Biofire Blood Culture Identification 2 panel

BioFire® Gastrointestinal (GI) Panel Overview

1 TEST. 22 TARGETS. ~1 HOUR.

When evaluating patients with severe or long-lasting gastroenteritis, it’s important to consider all possible causes—including bacterial, viral, or parasitic infections. Syndromic testing with the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel provides comprehensive answers fast—directly onsite—giving gastroenterologists the information they need to make timely and informed treatment decisions.

The FDA-cleared BioFire GI Panel tests for 22 of the most common pathogens associated with gastroenteritis—all from one patient sample and one easy to use reagent, with results available in about one hour.

Benefits of the GI Panel

FAST. EASY. COMPREHENSIVE.

Comprehensive Menu

The BioFire GI Panel can streamline workflow by providing faster and more comprehensive test results. Compared to traditional diagnostic methods, syndromic testing from the BioFire GI Panel can:

  • Reduce the number of laboratory tests on average from 3 to 11
  • Potentially reduce the number of send-out tests

Rapid Results

Greater laboratory efficiency: reduces time to results by 84%1

Impact antimicrobial therapy

Compared to traditional testing, BIOFIRE® GI Panel patients were less likely to be prescribed antibiotics2: from 40.9% to 36.2%

Panel Menu


Testimonials

Watch the videos below:

Laura Heireman

A validation study on Gastrointestinal / Joint Infection syndromic testing
AZ Sint Blasius – Dr. Laura Heireman.

Pr. Tristan Clark

What is the GASTROPOC trial ?


Information to download

BioFire® Gastrointestinal (GI) Panel Sheet

It contains the essential information on the panel, all on one sheet.

Download Now

BioFire® Gastrointestinal (GI) Pamphlet

To explore the benefits of the panel when used in routine testing.

Download Now


Other Available BIOFIRE® FilmArray® Panels

Contact Us

Fill in the form below to be contacted by your bioMérieux representative


By submitting this form, you agree to the processing of your personal data in accordance with our Privacy Statement.